Breckenridge gets FDA green light for generic Onfi
Breckenridge Pharmaceutical has received the Food and Drug Administration's blessing for clobazam tablets.
The product, which is the generic version of Lundbeck’s Onfi tablets, will be available in 10-mg and 20-mg tablets.
Clobazam tablets are a benzodiazepine indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients age 2 years old and older.
Onfi had a market value of $594 million for the 12 months ended Aug. 31, 2018, according to IQVIA data.
The product, which is the generic version of Lundbeck’s Onfi tablets, will be available in 10-mg and 20-mg tablets.
Clobazam tablets are a benzodiazepine indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients age 2 years old and older.
Onfi had a market value of $594 million for the 12 months ended Aug. 31, 2018, according to IQVIA data.